N4 Pharma PLC on Tuesday said its business outreach is ongoing as it continued to work on getting Nuvec, its delivery system for vaccines and cancer treatment, into clinic.
The Derby, England-based.
The following stocks are the leading risers and fallers on AIM in London on Tuesday.
AIM - WINNERS
N4 Pharma PLC, up 29% at 1.93 pence, 12-month range 1.40-3.80p. Company s.
N4 Pharma PLC (AIM:N4P) shares leapt 29% higher to 1.93p, up from a recent six-year low, on news of a new US patent and a change of chairman. Nuvec, the.